Robert Eugene Watson

Robert Eugene Watson, listed as board member, appears in our data through filings on CEL SCI Corp shares, published by SEC (Form 4). Over a trading history stretching from 7 May 2019 to 25 July 2025, the count stands at 6 filings.

Every open-market trade on record is a purchase: 5 purchases worth €68k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. In 2025 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €9,186. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 29 July 2025: an open-market purchase of €17k, in CEL SCI Corp. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.